{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:59:32Z","timestamp":1781650772080,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Research and Development Program Project of Ganzhou City","award":["GZ2024YLJ203"],"award-info":[{"award-number":["GZ2024YLJ203"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Androgen insensitivity syndrome (AIS) is a disorder caused by pathogenic mutations in the androgen receptor (AR) gene, leading to androgen resistance and impaired sex differentiation in 46,XY individuals. Despite increasing recognition of AR mutations, the pathogenic mechanisms and genotype\u2013phenotype correlations of many variants remain incompletely characterized. In this study, we identified a novel splice site mutation in the AR gene, c.2450-1G\u2009&gt;\u2009A, in a 46,XY patient presenting with a female phenotype, including primary amenorrhea and classical features of AIS, confirmed by chromosomal analysis and ultrasonography. Functional validation using minigene splicing assays demonstrated that this variant disrupts normal splicing, leading to an aberrant transcript lacking 6\u00a0bp at the 5\u2032 end of exon 7. This results in an aberrant in-frame transcript, c.2450_2455del, encoding a mutant protein with a three-amino acid deletion and a methionine insertion (p.Ile817_Val819delinsMet), while preserving the reading frame. In silico structural modeling suggested that this alteration may disturb the ligand-binding domain (LBD) conformation and receptor functionality. These findings highlight the pathogenic significance of splice-site variants in AR and provide mechanistic insight into AIS diagnosis and management.<\/jats:p>","DOI":"10.1186\/s12920-026-02374-x","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:49:19Z","timestamp":1776847759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel androgen receptor gene splice site mutation induces aberrant mRNA splicing and internal in-frame deletion in androgen insensitivity syndrome"],"prefix":"10.1186","volume":"19","author":[{"given":"Baoqiong","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gungao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"2374_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.20945\/2359-3997000000031","volume":"62","author":"RL Batista","year":"2018","unstructured":"Batista RL, Costa EMF, Rodrigues AS, Gomes NL, Faria JA Jr., Nishi MY, et al. Androgen insensitivity syndrome: a review. Arch Endocrinol Metab. 2018;62:227\u201335. https:\/\/doi.org\/10.20945\/2359-3997000000031.","journal-title":"Arch Endocrinol Metab"},{"key":"2374_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1210\/edrv-16-3-271","volume":"16","author":"CA Quigley","year":"1995","unstructured":"Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev. 1995;16:271\u2013321. https:\/\/doi.org\/10.1210\/edrv-16-3-271.","journal-title":"Endocr Rev"},{"key":"2374_CR3","doi-asserted-by":"publisher","first-page":"111146","DOI":"10.1016\/j.mce.2020.111146","volume":"523","author":"NC Hornig","year":"2021","unstructured":"Hornig NC, Holterhus PM. Molecular basis of androgen insensitivity syndromes. Mol Cell Endocrinol. 2021;523:111146. https:\/\/doi.org\/10.1016\/j.mce.2020.111146.","journal-title":"Mol Cell Endocrinol"},{"key":"2374_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1055\/s-0032-1324728","volume":"30","author":"IA Hughes","year":"2012","unstructured":"Hughes IA, Werner R, Bunch T, Hiort O. Androgen insensitivity syndrome. Semin Reprod Med. 2012;30:432\u201342. https:\/\/doi.org\/10.1055\/s-0032-1324728.","journal-title":"Semin Reprod Med"},{"key":"2374_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jpsychores.2017.08.009","volume":"101","author":"H Engberg","year":"2017","unstructured":"Engberg H, Strandqvist A, Nordenstrom A, Butwicka A, Nordenskjold A, Hirschberg AL, et al. Increased psychiatric morbidity in women with complete androgen insensitivity syndrome or complete gonadal dysgenesis. J Psychosom Res. 2017;101:122\u20137. https:\/\/doi.org\/10.1016\/j.jpsychores.2017.08.009.","journal-title":"J Psychosom Res"},{"key":"2374_CR6","doi-asserted-by":"publisher","first-page":"794","DOI":"10.21037\/tau.2016.08.09","volume":"5","author":"M Kathrins","year":"2016","unstructured":"Kathrins M, Kolon TF. Malignancy in disorders of sex development. Transl Androl Urol. 2016;5:794\u20138. https:\/\/doi.org\/10.21037\/tau.2016.08.09.","journal-title":"Transl Androl Urol"},{"key":"2374_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cca.2022.03.021","volume":"531","author":"D Zhou","year":"2022","unstructured":"Zhou D, Xu H, Shen X, Gu R, Chen Y, Chen G, et al. Complete androgen insensitivity syndrome caused by a novel mutation in the androgen receptor gene and its mechanism. Clin Chim Acta. 2022;531:94\u20139. https:\/\/doi.org\/10.1016\/j.cca.2022.03.021.","journal-title":"Clin Chim Acta"},{"key":"2374_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mce.2011.08.006","volume":"352","author":"J Jaaskelainen","year":"2012","unstructured":"Jaaskelainen J. Molecular biology of androgen insensitivity. Mol Cell Endocrinol. 2012;352:4\u201312. https:\/\/doi.org\/10.1016\/j.mce.2011.08.006.","journal-title":"Mol Cell Endocrinol"},{"key":"2374_CR9","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1210\/jc.2009-2146","volume":"95","author":"L Audi","year":"2010","unstructured":"Audi L, Fernandez-Cancio M, Carrascosa A, Andaluz P, Toran N, Piro C, et al. Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development. J Clin Endocrinol Metab. 2010;95:1876\u201388. https:\/\/doi.org\/10.1210\/jc.2009-2146.","journal-title":"J Clin Endocrinol Metab"},{"key":"2374_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0022-4731(89)90098-8","volume":"34","author":"AO Brinkmann","year":"1989","unstructured":"Brinkmann AO, Faber PW, van Rooij HC, Kuiper GG, Ris C, Klaassen P, et al. The human androgen receptor: domain structure, genomic organization and regulation of expression. J Steroid Biochem. 1989;34:307\u201310. https:\/\/doi.org\/10.1016\/0022-4731(89)90098-8.","journal-title":"J Steroid Biochem"},{"key":"2374_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.beem.2015.04.005","volume":"29","author":"NP Mongan","year":"2015","unstructured":"Mongan NP, Tadokoro-Cuccaro R, Bunch T, Hughes IA. Androgen insensitivity syndrome. Best Pract Res Clin Endocrinol Metab. 2015;29:569\u201380. https:\/\/doi.org\/10.1016\/j.beem.2015.04.005.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2374_CR12","doi-asserted-by":"publisher","first-page":"8970","DOI":"10.1038\/s41467-024-52989-w","volume":"15","author":"K Lengyel","year":"2024","unstructured":"Lengyel K, Rudra M, Berghof TVL, Leitao A, Frankl-Vilches C, Dittrich F, et al. Unveiling the critical role of androgen receptor signaling in avian sexual development. Nat Commun. 2024;15:8970. https:\/\/doi.org\/10.1038\/s41467-024-52989-w.","journal-title":"Nat Commun"},{"key":"2374_CR13","first-page":"3","volume":"37","author":"RA Davey","year":"2016","unstructured":"Davey RA, Grossmann M. Androgen receptor structure, function and biology: from bench to bedside. Clin Biochem Rev. 2016;37:3\u201315.","journal-title":"Clin Biochem Rev"},{"key":"2374_CR14","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1080\/14728222.2016.1192131","volume":"20","author":"S Sakkiah","year":"2016","unstructured":"Sakkiah S, Ng HW, Tong W, Hong H. Structures of androgen receptor bound with ligands: advancing understanding of biological functions and drug discovery. Expert Opin Ther Targets. 2016;20:1267\u201382. https:\/\/doi.org\/10.1080\/14728222.2016.1192131.","journal-title":"Expert Opin Ther Targets"},{"key":"2374_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000492261","volume":"12","author":"P Chauhan","year":"2018","unstructured":"Chauhan P, Rani A, Singh SK, Rai AK. Complete androgen insensitivity syndrome due to mutations in the DNA-binding domain of the human androgen receptor gene. Sex Dev. 2018;12:269\u201374. https:\/\/doi.org\/10.1159\/000492261.","journal-title":"Sex Dev"},{"key":"2374_CR16","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1210\/mend.15.10.0709","volume":"15","author":"D Nguyen","year":"2001","unstructured":"Nguyen D, Steinberg SV, Rouault E, Chagnon S, Gottlieb B, Pinsky L, et al. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome. Mol Endocrinol. 2001;15:1790\u2013802. https:\/\/doi.org\/10.1210\/mend.15.10.0709.","journal-title":"Mol Endocrinol"},{"key":"2374_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s13258-024-01611-w","volume":"47","author":"B Liao","year":"2025","unstructured":"Liao B, Xie W, Liu R, Zhang Q, Xie T, Jia D, et al. Identification of novel CDH23 heterozygous variants causing autosomal recessive nonsyndromic hearing loss. Genes Genomics. 2025;47:293\u2013305. https:\/\/doi.org\/10.1007\/s13258-024-01611-w.","journal-title":"Genes Genomics"},{"key":"2374_CR18","doi-asserted-by":"publisher","first-page":"e27199","DOI":"10.1016\/j.heliyon.2024.e27199","volume":"10","author":"Y Wang","year":"2024","unstructured":"Wang Y, He J, Dong F, Shou W, Feng X, Yang Y, et al. A novel mutation in GTPBP3 causes combined oxidative phosphorylation deficiency 23 by affecting pre-mRNA splicing. Heliyon. 2024;10:e27199. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27199.","journal-title":"Heliyon"},{"key":"2374_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"2374_CR20","doi-asserted-by":"publisher","first-page":"32819","DOI":"10.1038\/srep32819","volume":"6","author":"J Kansakoski","year":"2016","unstructured":"Kansakoski J, Jaaskelainen J, Jaaskelainen T, Tommiska J, Saarinen L, Lehtonen R, et al. Complete androgen insensitivity syndrome caused by a deep intronic pseudoexon-activating mutation in the androgen receptor gene. Sci Rep. 2016;6:32819. https:\/\/doi.org\/10.1038\/srep32819.","journal-title":"Sci Rep"},{"key":"2374_CR21","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/s41598-018-20691-9","volume":"8","author":"H Ono","year":"2018","unstructured":"Ono H, Saitsu H, Horikawa R, Nakashima S, Ohkubo Y, Yanagi K, et al. Partial androgen insensitivity syndrome caused by a deep intronic mutation creating an alternative splice acceptor site of the AR gene. Sci Rep. 2018;8:2287. https:\/\/doi.org\/10.1038\/s41598-018-20691-9.","journal-title":"Sci Rep"},{"key":"2374_CR22","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4103\/aja.aja_32_17","volume":"20","author":"SM Yuan","year":"2018","unstructured":"Yuan SM, Huang H, Tu CF, Du J, Xu DB, Lin G, et al. A rare polypyrimidine tract mutation in the androgen receptor gene results in complete androgen insensitivity syndrome. Asian J Androl. 2018;20:308\u201310. https:\/\/doi.org\/10.4103\/aja.aja_32_17.","journal-title":"Asian J Androl"},{"key":"2374_CR23","doi-asserted-by":"publisher","first-page":"e1797","DOI":"10.1210\/clinem\/dgac064","volume":"107","author":"NL Gomes","year":"2022","unstructured":"Gomes NL, Batista RL, Nishi MY, Lerario AM, Silva TE, de Moraes Narcizo A, et al. Contribution of clinical and genetic approaches for diagnosing 209 index cases with 46,XY differences of sex development. J Clin Endocrinol Metab. 2022;107:e1797\u2013806. https:\/\/doi.org\/10.1210\/clinem\/dgac064.","journal-title":"J Clin Endocrinol Metab"},{"key":"2374_CR24","doi-asserted-by":"publisher","unstructured":"Mason KA, Schoelwer MJ, Rogol AD. Androgens during infancy, childhood, and adolescence: physiology and use in clinical practice. Endocr Rev. 2020;41. https:\/\/doi.org\/10.1210\/endrev\/bnaa003.","DOI":"10.1210\/endrev\/bnaa003"},{"key":"2374_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5582\/irdr.2023.01024","volume":"12","author":"Z Chen","year":"2023","unstructured":"Chen Z, Li P, Lyu Y, Wang Y, Gao K, Wang J, et al. Molecular genetics and general management of androgen insensitivity syndrome. Intractable Rare Dis Res. 2023;12:71\u20137. https:\/\/doi.org\/10.5582\/irdr.2023.01024.","journal-title":"Intractable Rare Dis Res"},{"key":"2374_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3978\/j.issn.2223-4683.2013.09.15","volume":"2","author":"K Eisermann","year":"2013","unstructured":"Eisermann K, Wang D, Jing Y, Pascal LE, Wang Z. Androgen receptor gene mutation, rearrangement, polymorphism. Transl Androl Urol. 2013;2:137\u201347. https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2013.09.15.","journal-title":"Transl Androl Urol"},{"key":"2374_CR27","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s11427-017-9084-9","volume":"60","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gong C, Wang X, Qin M. AR mutations in 28 patients with androgen insensitivity syndrome (Prader grade 0\u20133). Sci China Life Sci. 2017;60:700\u20136. https:\/\/doi.org\/10.1007\/s11427-017-9084-9.","journal-title":"Sci China Life Sci"},{"key":"2374_CR28","doi-asserted-by":"publisher","first-page":"e52764","DOI":"10.15252\/embr.202152764","volume":"22","author":"S El Kharraz","year":"2021","unstructured":"El Kharraz S, Dubois V, van Royen ME, Houtsmuller AB, Pavlova E, Atanassova N, et al. The androgen receptor depends on ligand-binding domain dimerization for transcriptional activation. EMBO Rep. 2021;22:e52764. https:\/\/doi.org\/10.15252\/embr.202152764.","journal-title":"EMBO Rep."},{"key":"2374_CR29","doi-asserted-by":"publisher","first-page":"14388","DOI":"10.1038\/ncomms14388","volume":"8","author":"M Nadal","year":"2017","unstructured":"Nadal M, Prekovic S, Gallastegui N, Helsen C, Abella M, Zielinska K, et al. Structure of the homodimeric androgen receptor ligand-binding domain. Nat Commun. 2017;8:14388. https:\/\/doi.org\/10.1038\/ncomms14388.","journal-title":"Nat Commun"},{"key":"2374_CR30","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/med.21548","volume":"39","author":"N Elshan","year":"2019","unstructured":"Elshan N, Rettig MB, Jung ME. Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-ligand binding domain. Med Res Rev. 2019;39:910\u201360. https:\/\/doi.org\/10.1002\/med.21548.","journal-title":"Med Res Rev"},{"key":"2374_CR31","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/iju.13137","volume":"23","author":"Y Imamura","year":"2016","unstructured":"Imamura Y, Sadar MD. Androgen receptor targeted therapies in castration-resistant prostate cancer: bench to clinic. Int J Urol. 2016;23:654\u201365. https:\/\/doi.org\/10.1111\/iju.13137.","journal-title":"Int J Urol"},{"key":"2374_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/RRU.S157116","volume":"10","author":"Y Ito","year":"2018","unstructured":"Ito Y, Sadar MD. Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens. Res Rep Urol. 2018;10:23\u201332. https:\/\/doi.org\/10.2147\/RRU.S157116.","journal-title":"Res Rep Urol"},{"key":"2374_CR33","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1210\/jcem.86.9.7825","volume":"86","author":"AL Boehmer","year":"2001","unstructured":"Boehmer AL, Brinkmann O, Bruggenwirth H, van Assendelft C, Otten BJ, Verleun-Mooijman MC, et al. Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab. 2001;86:4151\u201360. https:\/\/doi.org\/10.1210\/jcem.86.9.7825.","journal-title":"J Clin Endocrinol Metab"},{"key":"2374_CR34","doi-asserted-by":"publisher","first-page":"e4599","DOI":"10.1002\/pro.4599","volume":"32","author":"C Helsen","year":"2023","unstructured":"Helsen C, Rocca MS, Nguyen TT, Eerlings R, Lee XY, De Block S, et al. Study of novel androgen receptor V770 variant in androgen insensitivity syndrome patients reveals the transitional state of the androgen receptor ligand binding domain homodimer. Protein Sci. 2023;32:e4599. https:\/\/doi.org\/10.1002\/pro.4599.","journal-title":"Protein Sci"},{"key":"2374_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ebiom.2018.09.047","volume":"36","author":"N Lek","year":"2018","unstructured":"Lek N, Tadokoro-Cuccaro R, Whitchurch JB, Mazumder B, Miles H, Prentice P, et al. Predicting puberty in partial androgen insensitivity syndrome: Use of clinical and functional androgen receptor indices. EBioMedicine. 2018;36:401\u20139. https:\/\/doi.org\/10.1016\/j.ebiom.2018.09.047.","journal-title":"EBioMedicine"},{"key":"2374_CR36","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/humu.22046","volume":"33","author":"B Gottlieb","year":"2012","unstructured":"Gottlieb B, Beitel LK, Nadarajah A, Paliouras M, Trifiro M. The androgen receptor gene mutations database: 2012 update. Hum Mutat. 2012;33:887\u201394. https:\/\/doi.org\/10.1002\/humu.22046.","journal-title":"Hum Mutat"},{"key":"2374_CR37","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1210\/jc.2016-1990","volume":"101","author":"NC Hornig","year":"2016","unstructured":"Hornig NC, Ukat M, Schweikert HU, Hiort O, Werner R, Drop SL, et al. Identification of an AR mutation-negative class of androgen insensitivity by determining endogenous AR activity. J Clin Endocrinol Metab. 2016;101:4468\u201377. https:\/\/doi.org\/10.1210\/jc.2016-1990.","journal-title":"J Clin Endocrinol Metab"},{"key":"2374_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s0960-0760(97)00001-0","volume":"61","author":"CL Bevan","year":"1997","unstructured":"Bevan CL, Hughes IA, Patterson MN. Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome. J Steroid Biochem Mol Biol. 1997;61:19\u201326. https:\/\/doi.org\/10.1016\/s0960-0760(97)00001-0.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2374_CR39","doi-asserted-by":"publisher","first-page":"1822 e1821","DOI":"10.1016\/j.fertnstert.2005.11.063","volume":"85","author":"J Turek-Plewa","year":"2006","unstructured":"Turek-Plewa J, Eckersdorf-Mastalerz A, Kaluzewski B, Helszer Z, Trzeciak WH. A mutation c.C2812T in the androgen receptor gene resulting in Pro817Leu substitution may affect dimerization of the androgen receptor and result in androgen insensitivity syndrome. Fertil Steril. 2006;85:1822 e1821-1824. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.11.063.","journal-title":"Fertil Steril."},{"key":"2374_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/09513590.2012.705378","volume":"29","author":"N Mendoza","year":"2013","unstructured":"Mendoza N, Motos MA. Androgen insensitivity syndrome. Gynecol Endocrinol. 2013;29:1\u20135. https:\/\/doi.org\/10.3109\/09513590.2012.705378.","journal-title":"Gynecol Endocrinol"},{"key":"2374_CR41","doi-asserted-by":"publisher","first-page":"8313162","DOI":"10.1155\/2017\/8313162","volume":"2017","author":"F Pritsini","year":"2017","unstructured":"Pritsini F, Kanakis GA, Kyrgios I, Kotanidou EP, Litou E, Mouzaki K, et al. Psychological aspects of androgen insensitivity syndrome: Two cases illustrating therapeutical challenges. Case Rep Endocrinol. 2017;2017:8313162. https:\/\/doi.org\/10.1155\/2017\/8313162.","journal-title":"Case Rep Endocrinol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-026-02374-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:33:16Z","timestamp":1781649196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-026-02374-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2374"],"URL":"https:\/\/doi.org\/10.1186\/s12920-026-02374-x","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"14 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study was approved by Ethics Committee of Ganzhou Maternal and Child Health Hospital, Ganzhou, China (Approval No. GZMC2024-103). The family signed a written informed consent form to participate in the clinical study. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient's family for publication of this result and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}